Hemagglutinin-specific CD4+ T-cell receptor (HA-specific TCR) (HA-specific TCR)

The Hemagglutinin-specific CD4+ T-cell receptor (TCR) is a heterodimeric surface protein on helper T cells that recognizes influenza virus hemagglutinin (HA) peptides presented by MHC class II molecules (PMID: 25108025). This recognition is vital for the induction of high-affinity antibody responses and long-term immunological memory against influenza (PMID: 22460820). Upon engagement with the peptide-MHC complex, the TCR triggers signaling through the CD3 complex, leading to T-cell proliferation and the secretion of cytokines like IL-2 and IFN-gamma (PMID: 18490745). These receptors are primary targets in vaccine design, where the goal is to elicit broad-spectrum CD4+ T-cell help to combat antigenic drift in influenza viruses (PMID: 29162712). Therapeutic strategies also explore TCR-engineered T cells and peptide-based immunotherapies to enhance viral clearance (PMID: 30249041). However, challenges include potential cross-reactivity with self-peptides, which may lead to autoimmune conditions following infection or vaccination (PMID: 26135967). The diversity of the TCR repertoire for HA epitopes determines the breadth of the immune response across different viral strains (PMID: 28219924). Monitoring these receptors using MHC-II tetramers provides insights into the efficacy of seasonal vaccines and the potential for pandemic preparedness (PMID: 24336226).

Other names

Influenza hemagglutinin-specific T-cell receptorHA-reactive CD4+ TCRMHC class II-restricted HA-specific TCRHemagglutinin-specific TCR

Recognition of influenza hemagglutinin-derived peptides presented by MHC class II molecules, triggering intracellular signaling cascades that lead to CD4+ T-cell activation, proliferation, and the secretion of cytokines to coordinate the adaptive immune response.